Ballooning 340B market reaches almost 15% of 2021 US pharma sales, IQVIA finds
The tale of a booming federal drug discount program, which pharma companies have sought to curtail, has often been told but rarely with new numbers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
